November 2025
The global pharmaceutical drug delivery market size is calculated at USD 2.07 trillion in 2025 and is projected to hit around USD 3.18 trillion by 2034 with a CAGR of 4.90%.
September 2025
The global biopharmaceutical packaging market size was evaluated at USD 95.35 billion in 2024 and is predicted to hit around USD 179.66 billion by 2034, growing at a CAGR of 6.54%.
May 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
April 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 88.85 billion in 2025, growing at a CAGR of 7.28%.
April 2026
The global transdermal drug delivery systems market size was evaluated at USD 78.20 billion in 2025 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
April 2026
The global intranasal drug delivery devices market size surpassed USD 1868.61 million in 2025 and is projected to hit around USD 4949.45 million by 2035, with a noteworthy CAGR of 10%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
January 2026
The injectable drug delivery market size was valued at USD 764.6 billion in 2025 and is projected to hit around USD 1,719.57 billion by 2035 with a CAGR of 8.45%.
December 2025
The drug delivery devices market size is valued at USD 303.28 billion in 2025 and is expected to hit around USD 533.31 billion by 2035, growing at a CAGR of 5.81% from 2026 to 2035.
December 2025
The global controlled release drug delivery market size is projected to hit around USD 160.09 billion by 2035 from USD 66.80 billion in 2025, with a CAGR of 9.13%.
December 2025
The advanced drug delivery market size is calculated at USD 89.83 billion in 2025 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
December 2025
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 49.39 billion by 2034, growing at a CAGR of 7.61%.
November 2025
The implantable drug delivery devices market size is valued at USD 13.29 billion in 2025 and is expected to hit around USD 21.00 billion by 2034 with a CAGR of 5.22%.
November 2025
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 299.58 billion by 2034, growing at a CAGR of 9.14%.
October 2025
The global drug and gene delivery devices market size is projected to hit around USD 1738.73 billion by 2034 from USD 792.67 billion in 2025 with a CAGR of 9.12%.
October 2025
The global RNA interference drug delivery market size is evaluated at USD 118.18 billion in 2025 and is predicted to hit around USD 528.60 billion by 2034, growing at a CAGR of 18.11%.
August 2025
The global liposome drug delivery market size reached USD 5.59 billion in 2024 and is projected to surpass around USD 13.12 billion by 2034, with a CAGR of 8.91%.
July 2025
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
January 2025
The global pulmonary drug delivery systems market size is projected to hit around USD 87.73 billion by 2034 from USD 55.74 billion in 2024 with a CAGR of 4.64%.
January 2025
The global subcutaneous drug delivery devices market size was valued at USD 33.56 billion in 2024 and is projected to hit around USD 69.94 billion by 2034 with a CAGR of 7.62%.
September 2025
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
August 2025
The global pharmaceutical CRO market size was evaluated at USD 44.58 billion in 2024 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
July 2025
The oral transmucosal drugs market size was valued at USD 36.72 billion in 2024 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
July 2025
The pharmaceutical quality control market size is projected to surpass around USD 40.16 billion by 2034 from USD 12.86 billion in 2024 with a CAGR of 12.06%.
June 2025
The global inhalable drugs market size was valued at USD 35.44 billion in 2024 and is projected to cross around USD 65.51 billion by 2034 with a CAGR of 5.57%.
August 2025
The global PEGylation proteins technology market size was evaluated at USD 4.56 billion in 2024 and is predicted to hit around USD 9.17 billion by 2034, growing at a CAGR of 7.24%.
August 2025
The global syringes market size was estimated at USD 24.59 billion in 2024 and is predicted to surpass around USD 59.39 billion by 2034 with a solid CAGR of 9.22%.
August 2025
The global nucleic acid aptamers market size was evaluated at USD 257.93 million in 2024 and is predicted to hit around USD 1,267.63 million by 2034, growing at a CAGR of 17.26%.
July 2025
The global chemotherapy market size was evaluated at USD 9.53 billion in 2024 and is projected to worth around USD 19.69 billion by 2034 with a CAGR of 7.53%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com